SOST and diabetes mellitus: Now that Picicca et al. demonstrated that diabetes caused osteocytes to alter over time and upregulate the sclerostin gene, we assumed that Romosozumab may be a very effective drug in treating DOP reasonably, which is also a potential research direction (85).